Invalidity dossier

US 9027032

System and method for providing additional functionality to existing software in an integrated manner

Current assignee: Unified Patents

Added 5/12/2026, 11:39:20 PM

At a glanceNo PTAB challenges2 lawsuits on fileasserted by Unified PatentsSoftware Technology & Computing Systems (T)

Active provider: DeepSeek · deepseek-flash

Patent summary

Title, assignee, inventors, filing/issue dates, abstract, and a plain-language overview of the claims.

✓ Generated

Here's a concise summary of US Patent 9027032:

Patent Number: US9027032B2

Title: System and method for providing additional functionality to existing software in an integrated manner

Assignee: Damaka Inc.

Inventors:

  • Sivakumar Chaturvedi
  • Satish Gundabathula
  • Rashmi Hiremath

Filing Date: 2013-09-11

Issue Date: 2015-05-05

Abstract: An improved system and method are disclosed for improving functionality in software applications. In one example, the method includes a mobile device having a network interface, a processor, and a memory configured to store a plurality of instructions. The instructions include instructions for a superblock application having instructions for a function block included therein. The function block is configured to provide functions that are accessible to the superblock application via an application programming interface (API). The functions are provided within the superblock application itself and are accessible within the superblock application without switching context to another application on the mobile device.

Plain-Language Overview of Independent Claims:

  • Independent Claim 1 (Method Claim): This claim describes a method for adding new functions to an existing software application (called a "superblock application") on a mobile device without making the user switch to a different application. The method involves including a "function block" within the superblock application's instructions. This function block provides extra capabilities, such as communication or data handling, through an Application Programming Interface (API). When the superblock application needs one of these extra functions, it calls the function block via the API. The key is that these functions are performed and displayed within the superblock application itself, avoiding disruptive context switching. The function block determines if it has the requested capability, if it can display or use it on the device (e.g., if a microphone is present for audio), and if external services are needed and available, or if the superblock application needs to help display or use the capability and can do so.

  • Independent Claim 13 (System Claim): This claim describes a mobile device system configured to provide additional functionality to a superblock application in an integrated manner. The system includes a network interface, a processor, and memory. The memory stores the superblock application, which itself contains a "function block." This function block provides extra capabilities to the superblock application via an API, making them available and usable directly within the superblock application without requiring context switching to another application. The system's components are arranged to allow the function block to perform these functions seamlessly within the superblock's environment.

CAFC 2026 Dockets Search:
A search of the CAFC 2026 dockets for US9027032B2 did not return any specific litigation or scheduled cases related to this patent number as of April 26, 2026. The search results provided general information about accessing CAFC case records and scheduled cases for upcoming months.

Generated 5/28/2026, 6:47:31 AM

Cases on file (2)

Group view →

Specific litigation cases in our database that name US patent 9027032. The free-form analysis below may also discuss cases beyond this list.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

✓ Generated

I'll search for litigation involving US patent 9027032 across the sources specified.

I found significant litigation. Let me gather details on the specific cases.

Let me verify whether there are additional cases and confirm current status details.

Known Litigation Involving US Patent 9027032

Based on searches of patent-litigation trackers (Unified Patents Litigation Portal, RPX Empower, Docket Alarm, Justia Dockets, UniCourt, and Ex Parte litigation analytics), I found two (2) active district court cases asserting U.S. Patent No. 9,027,032 ("the '032 Patent"). Both were filed on the same day in the U.S. District Court for the Eastern District of Texas by Damaka, Inc. and remain pending. I found no other litigation involving this patent number.


Case 1 — Damaka, Inc. v. Cisco Systems, Inc.

Field Detail
Plaintiff Damaka, Inc.
Defendant Cisco Systems, Inc.
Jurisdiction U.S. District Court for the Eastern District of Texas, Marshall Division
Case No. 2:25-cv-00593
Filing Date May 30, 2025
Presiding Judge Roy S. Payne; Referring Judge Robert W. Schroeder
Accused products "All versions and variants of the Cisco Web and Mobile A/V Applications, and Cisco's A/V SDKs, since 2019" — specifically including the Cisco "Webex" mobile/web application and the Webex SDKs
Asserted claims of the '032 Patent Claims 15–20 (per Cisco's Preliminary Invalidity Contentions; asserted in Damaka's Nov. 13, 2025 infringement contentions)
Co-asserted patents Six patents total: '032, '092 (9,578,092), '744 (9,270,744), '046 (11,576,046), '362 (11,930,362), '116 (12,279,116)
Current status Pending. Cisco filed a partial motion to dismiss (Dkt. 26, Oct. 2, 2025); an earlier motion to dismiss was denied (Dkt. 22, Sept. 11, 2025). Scheduling conference held Nov. 13, 2025. Cisco served Preliminary Invalidity Contentions Jan. 15, 2026. Damaka's Infringement Contentions were served Nov. 13, 2025. No trial outcome to date.

Case 2 — Damaka, Inc. v. The Cigna Group, et al.

Field Detail
Plaintiff Damaka, Inc.
Defendants The Cigna Group; Cigna Health and Life Insurance Company; Cigna Healthcare of Texas, Inc.
Jurisdiction U.S. District Court for the Eastern District of Texas, Marshall Division
Case No. 2:25-cv-00594
Filing Date May 30, 2025
Presiding Judge Rodney Gilstrap
Accused products "All versions and variants of the MDLIVE application, including … MDLIVE for desktop, MDLIVE for Android, MDLIVE for iOS, and MDLIVE for iPad, since 2019"
Asserted claims of the '032 Patent At least claim 15 (independent method claim)
Co-asserted patents Five patents: '032, '092, '744, '046, '362 (note: the '116 patent asserted against Cisco is not asserted against Cigna)
Current status Pending. Defendants answered and counterclaimed (Aug. 18, 2025); Damaka filed a First Amended Complaint (Sept. 2025); Defendants filed a renewed motion to dismiss for patent ineligibility under 35 U.S.C. § 101 (Dkt. 33), with supplemental briefing filed Aug. 19, 2026. Claim-construction/prehearing statement filed Aug. 18, 2026. No trial outcome to date.

Related PTAB proceeding (context, already covered in your prior section)

While not a "litigation" in the district-court sense, note that Cisco Systems, Inc. v. Damaka, Inc., IPR2026-00206 (PTAB, filed Jan. 13, 2026) challenged claims 1–21 of the '032 Patent and was denied institution on May 6, 2026 on discretionary/non-merits grounds. This is the PTAB counterpart to Case 1 above. (Per your earlier section — not repeated here.)


Important caveats on my findings

  1. Completeness. I confirmed the two cases above through multiple independent trackers that all list the '032 Patent in the complaints. However, I could not complete a final cross-check of every docket (e.g., the full RPX Empower campaign list and the Unified Patents litigation caselist) before hitting my search limit. It is possible additional defendants were named in separate, later-filed suits that did not surface in my searches. Treat the list above as complete for the May 30, 2025 filing wave but potentially incomplete for any post-2025 filings.

  2. Procedural dates at the edges. Docket entries cited here (e.g., Dkt. 33, Dkt. 71, Dkt. 73 in Case 2; the Nov. 13, 2025 contentions and Jan. 15, 2026 invalidity contentions in Case 1) come from third-party docket aggregators and complaint text, not from a direct PACER retrieval. Verify against PACER primary sources before relying on them.

  3. No CAFC appeal found. No Federal Circuit appeal involving the '032 Patent appears in the results. (Your earlier summary also reported no CAFC 2026 docket hits, which is consistent.)

  4. Unified Patents attribution conflict — flag. Your prior "PTAB challenges" and "NPE/troll-pattern" sections state the petitioner in IPR2026-00206 was Unified Patents. The litigation-tracking results I retrieved instead identify the petitioner as Cisco Systems, Inc. (e.g., IPVerse/Greyb lists "Petitioner: Cisco Systems, Inc." for IPR2026-00206, and Docket Alarm lists Cisco as petitioner for the related IPR2026-00206/00207/00208/00209/00210 family filed Jan. 13, 2026). These two attributions directly contradict each other, and I cannot resolve which is correct from the available evidence. It is worth noting that a separate IPR you cited (Unified Patents v. Dolby, re the '577 patent) is a distinct matter and may have been conflated with this patent. Recommend verifying the petitioner of IPR2026-00206 from the PTAB docket directly.

  5. No ITC investigation involving the '032 Patent was found.


Summary

The '032 Patent is currently being asserted in two pending E.D. Tex. lawsuits, both filed May 30, 2025 by Damaka, Inc.: against Cisco Systems, Inc. (2:25-cv-00593, Judge Payne) and against The Cigna Group / Cigna Health / Cigna Healthcare of Texas (2:25-cv-00594, Judge Gilstrap). Neither has reached trial or judgment. A related Cisco-filed IPR (IPR2026-00206) was denied institution. No other litigation (CAFC, ITC, or additional district court defendants) was identified for this patent number.

Generated 9/30/2026, 8:22:23 PM

Proceedings on file (1)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

Current assignee: Unified Patents

1 discretionary denial

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

Proceedings overview

One inter partes review (IPR) proceeding, IPR2026-00206, has been filed against US Patent 9027032. The IPR was denied institution, meaning the challenged claims were not reviewed on the merits and remain sustained. This outcome gives a defendant a stronger defensive posture regarding the patent, as it has withstood a PTAB challenge at the institution phase.

IPR2026-00206 — Cisco Systems, Inc. v. Damaka Inc.

  • Type: Inter Partes Review
  • Filed: 2026-01-13
  • Status: Discretionary Denial. The Patent Trial and Appeal Board (PTAB) declined to institute the inter partes review.
  • Judge panel: The decision on institution was issued by John A. Squires, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office.
  • Petition grounds: The exact claims challenged and specific prior art for IPR2026-00206 are not explicitly detailed in the public records found, but similar IPRs filed by Cisco Systems, Inc. against Damaka Inc. on related patents challenged claims based on obviousness under 35 U.S.C. § 103 over prior art references such as Abuan, Platt, and Morrison. It is highly probable that IPR2026-00206 similarly challenged claims of US9027032B2 under § 102 and/or § 103.
  • Institution decision: Institution was denied on 2026-05-06. The denial was based on "discretionary and non-merits considerations" by the Director of the USPTO. This typically implies a denial under doctrines such as Fintiv or other discretionary rules, which may consider factors like parallel district court litigation or recent USPTO policy shifts, such as the new U.S. manufacturing footprint factor. Cisco Systems, Inc. is involved in parallel district court litigation against Damaka Inc. (e.g., 2:25-cv-00593 in the E.D. Texas, filed 2025-05-30), which likely factored into the discretionary denial. Cisco argued against discretionary denial by highlighting its U.S. manufacturing operations, Damaka's lack thereof, and the diligence in filing the petitions after receiving infringement contentions.
  • Final Written Decision: Not issued, as institution was denied.
  • Settlement / termination: Not applicable, as institution was denied.
  • Appeal: Not applicable, as institution was denied.
  • Defensive value: This proceeding demonstrates that the patent owner, Damaka Inc., successfully defended against the IPR petition at the institution stage. While the claims of US9027032B2 were not adjudicated on the merits by the PTAB, the discretionary denial means that this specific challenge did not proceed to trial. This could make it more difficult for Cisco (or parties in privity with Cisco) to bring a similar IPR challenge on the same grounds.

Strategic summary

All claims of US9027032B2 remain untested on their patentability merits before the PTAB. The sole IPR proceeding filed against the patent, IPR2026-00206, was denied institution based on discretionary and non-merits considerations by the Director of the USPTO. Therefore, no claims of 9027032 are currently canceled or sustained by a PTAB Final Written Decision. All claims are effectively "sustained" against this particular challenge by virtue of the non-institution.

The estoppel landscape is impacted by the discretionary denial. Typically, a denial of institution without reaching the merits does not trigger claim-by-claim estoppel under 35 U.S.C. § 315(e)(2). However, argument-based estoppel might still apply to Cisco Systems, Inc. and its privies for the specific grounds and arguments raised in the petition for IPR2026-00206. The PTAB's recent emphasis on discretionary denials, particularly those involving parallel litigation and the new "U.S. manufacturing footprint" factor, suggests a trend towards limiting IPRs when district court cases are ongoing. For a defendant currently facing assertion of this patent, prior-art grounds not raised (or not reasonably able to have been raised) by Cisco, or by a non-estopped party, could still be available for a new IPR petition.

A pattern signal observed is that Cisco Systems, Inc. has filed multiple IPRs against Damaka Inc. for related patents, and several of these have been "Not Instituted - Procedural". This suggests that Damaka Inc. has successfully leveraged procedural or discretionary arguments to prevent institution in these PTAB challenges. This indicates that the patent owner is actively and effectively defending its patent portfolio at the PTAB.

Recommended next steps

Since IPR2026-00206 was denied institution, there is no Final Written Decision (FWD) to link to for claim invalidation. The claims of US9027032B2 have not been invalidated by the PTAB.

For a defendant considering challenging this patent, it would be crucial to:

  1. Obtain and thoroughly review the "Notice of Decisions on Institution" for IPR2026-00206, issued on 2026-05-06, to understand the precise reasoning for the discretionary denial. This document will illuminate the specific factors that led to the denial and may provide guidance on what grounds or circumstances might avoid a similar discretionary denial in a future petition.
  2. Evaluate the existing district court litigation between Damaka Inc. and Cisco Systems, Inc. The outcome of these cases, and any associated validity arguments made in that forum, could influence future PTAB proceedings or settlement negotiations.
  3. Consider whether any new prior art or significantly different unpatentability arguments exist that were not (or could not reasonably have been) raised in IPR2026-00206. This would be critical to overcome any potential argument-based estoppel.
  4. Assess the applicability of the USPTO's evolving discretionary denial policies, especially concerning parallel litigation and the U.S. manufacturing footprint, to your specific situation. The Director's memorandum issued March 11, 2026, introduced these considerations.

Generated 5/28/2026, 6:47:58 AM

Ownership chain (3)

Asserters network →

Structured records extracted from the assignment-history narrative below. Each entity links to its full ownership-network profile.

  1. 2013-09-11 · recorded 2013-11-20 · reel 031317/0014 · Assignment

    CHATURVEDI, SIVAKUMAR; GUNDABATHULA, SATISH; HIREMATH, RASHMIDAMAKA, INC.

    Correspondent: KENNETH W PARKER · AKERMAN SENTERFITT

    initial assignment of inventor's rights to the original assignee

  2. 2017-02-06 · recorded 2017-03-29 · reel 038676/0950 · Merger

    DAMAKA, INC.BROADSOFT, INC.

    Correspondent: DANIEL J SANTANI · COOLEY

    merger

  3. 2018-02-02 · recorded 2018-03-12 · reel 041834/0001 · Merger

    BROADSOFT, INC.Cisco Technology, Inc.

    Correspondent: ANNE M. SHAVER · THE LAW OFFICE OF ANNE M. SHAVER

    merger

Assignment history

Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.

✓ Generated

Inventors

  • Sivakumar Chaturvedi: Likely employed by Damaka Inc. at the time of filing.
  • Satish Gundabathula: Likely employed by Damaka Inc. at the time of filing.
  • Rashmi Hiremath: Likely employed by Damaka Inc. at the time of filing.

All three inventors formally assigned their rights to Damaka Inc. on the same day the patent application was filed (2013-09-11), which is standard practice for employee-inventors. No unusual patterns of departure within 12 months are evident from the provided data.

Original assignee

Damaka Inc.
Damaka Inc. was a company specializing in secure, peer-to-peer mobile collaboration and communication software, which aligns with the functionality described in the patent (e.g., instant messaging, audio/video calls, file sharing within applications). They shipped products embodying the claims in their line of business.
Damaka Inc. was acquired by Broadsoft Inc. in February 2017, and Broadsoft Inc. was subsequently acquired by Cisco Technology, Inc. in February 2018. The current operational status of the original Damaka Inc. entity post-acquisition is likely non-operating, its business absorbed into Broadsoft/Cisco.

Assignment timeline

The USPTO Assignment Center search by patent number 9027032 returns only the initial assignment from inventors to Damaka Inc. However, subsequent corporate mergers affecting the patent's ownership are recorded via general assignment documents (merger certificates) which assert transfer of "all patents and patent applications" of the merging entity, even if individual patent numbers are not explicitly listed in the document itself.

  • 2013-09-11 (executed) / recorded 2013-11-20 — Reel 031317/0014

    • Conveyance: Assignment
    • Assignor: CHATURVEDI, SIVAKUMAR; GUNDABATHULA, SATISH; HIREMATH, RASHMI
    • Assignee: DAMAKA, INC.
    • Correspondent: KENNETH W PARKER; AKERMAN SENTERFITT; 811 WEST PALMETTO PARK ROAD; BOCA RATON; FL 33486
    • Context: Initial assignment of inventor's rights to the original assignee, Damaka Inc.
  • 2017-02-06 (executed) / recorded 2017-03-29 — Reel 038676/0950

    • Conveyance: Merger
    • Assignor: DAMAKA, INC.
    • Assignee: BROADSOFT, INC.
    • Correspondent: DANIEL J SANTANI; COOLEY LLP; 1299 PENNSYLVANIA AVE., NW SUITE 700; WASHINGTON; DC 20004
    • Context: Merger of Damaka Inc. into Broadsoft Inc., transferring all assets including patents. (Note: US9027032 not specifically listed in this general merger document, but covered by its terms.)
  • 2018-02-02 (executed) / recorded 2018-03-12 — Reel 041834/0001

    • Conveyance: Merger
    • Assignor: BROADSOFT, INC.
    • Assignee: CISCO TECHNOLOGY, INC.
    • Correspondent: ANNE M. SHAVER; THE LAW OFFICE OF ANNE M. SHAVER, P.C.; 225 CONSTITUTION AVENUE, NE; WASHINGTON; DC 20002
    • Context: Merger of Broadsoft Inc. into Cisco Technology, Inc., transferring all assets including patents. (Note: US9027032 not specifically listed in this general merger document, but covered by its terms.)

Timeline diagram

timeline
    title Ownership of US 9027032
    2013 : Filed and assigned to Damaka Inc
    2015 : Issued
    2017 : Damaka Inc merged into Broadsoft Inc
    2018 : Broadsoft Inc merged into Cisco Technology Inc
    2025 : Damaka Inc sues Cisco Systems Inc
    2026 : IPR filed by Unified Patents

NPE / troll-pattern signals

  1. Shell-entity transfer — Unclear. While the recorded transfers (mergers) were between operating companies, the plaintiff "DAMAKA, INC." in the 2025 litigation against Cisco Systems, Inc. is likely a non-operating entity at that point, given its prior acquisition.
  2. Known asserter in the chain — Not present as an assignee in the recorded chain. However, Unified Patents (a known anti-NPE entity) has filed an IPR against this patent, and "DAMAKA, INC." (the plaintiff in the 2025 litigation) is acting as an asserting entity.
  3. Repeat correspondent across the chain — Not present. Different correspondents are listed for each recorded assignment (Reel 031317/0014, Reel 038676/0950, Reel 041834/0001).
  4. Cascading transfers — Not present. The transfers occur years apart, aligning with corporate acquisitions (2013, 2017, 2018).
  5. Pre-litigation transfer — Not present. The last recorded merger affecting ownership was in 2018. The litigation was filed in 2025, which is outside the 6-month window for this signal.
  6. Bankruptcy fire-sale — Not present. The transfers were a result of corporate mergers and acquisitions, not bankruptcy proceedings.
  7. Privateering — Unclear. The litigation where "DAMAKA, INC." (the original assignee) is suing "CISCO SYSTEMS, INC." (the ultimate acquirer of Damaka's assets, including this patent via mergers) is highly unusual. This suggests a complex arrangement where the original Damaka entity or its principals may have retained or re-acquired assertion rights, or a separate entity with the same name was formed for assertion. This could functionally resemble privateering if an operating company is covertly funding the assertion against competitors.
  8. Defensive aggregator (anti-NPE) — Not present as an assignee in the chain. However, Unified Patents is petitioning for an IPR (IPR2026-00206), which is a defensive action against patent assertion.

Verdict

NPE — high confidence

The primary reason for this verdict is the active litigation where "DAMAKA, INC." (the original assignee, which was acquired in 2017) is listed as the plaintiff against "CISCO SYSTEMS, INC." (the parent company of the ultimate assignee via merger in 2018). This indicates that the asserting "DAMAKA, INC." entity is highly likely a non-operating company (an NPE) pursuing assertion rights, likely stemming from a complex arrangement or carve-out related to the original acquisition. The filing of an IPR by Unified Patents further suggests this is a patent being asserted by an NPE.

USPTO Assignment Center search for US9027032: https://assignmentcenter.uspto.gov/patents/9027032

Generated 5/28/2026, 6:48:16 AM

Prior art

Earlier patents, publications, and products that may anticipate or render the claims unpatentable.

✓ Generated

The USPTO provides a "Patent Public Search" tool for searching patents and patent application publications. I will use this to identify prior art for US patent 9027032.

To find the most relevant prior art, I will examine the "Cited By" section of the patent record for US9027032B2, which lists references that were considered by the patent examiner during prosecution. The full citation, publication/filing date, a brief description, and which claim(s) it potentially anticipates will be provided for each relevant reference.

Please note that identifying whether a prior art reference "anticipates" a claim under 35 U.S.C. § 102 requires a detailed, claim-by-claim analysis that compares every element of a claim to the disclosure of the prior art. This is typically a complex legal determination. I will highlight potential areas of overlap based on the descriptions, but a definitive determination of anticipation would require a more in-depth legal review.

Due to the limitations of this environment, I cannot directly access the live USPTO database and navigate its interface to perform a detailed "Cited By" search and then parse each individual cited patent to extract all the requested details (full citation, publication/filing date, description, and specific claim anticipation).

To provide the most relevant prior art, I would require direct access to the full patent document of US9027032B2, specifically its "References Cited" section, and then the ability to individually retrieve and analyze each of those cited patents.

However, based on the provided patent summary and independent claims, the core innovation of US9027032B2 lies in integrating additional functionality (via a "function block" and API) within a "superblock application" on a mobile device, eliminating the need for context switching to a separate application. Therefore, relevant prior art would likely involve:

  • Systems and methods for extending application functionality.
  • API-based integration in mobile environments.
  • Techniques for avoiding context switching between applications on mobile devices.
  • Modular software architectures, especially those involving embedding one software component within another.

Without direct access to the "References Cited" section of US9027032B2, I cannot provide the specific prior art patents and their detailed analysis.

Generated 5/28/2026, 6:47:42 AM

Obviousness

Combinations of prior art that suggest the claimed invention would have been obvious under 35 U.S.C. § 103.

✓ Generated

I cannot perform an obviousness analysis for US Patent 9027032 under 35 U.S.C. § 103 as requested.

The provided "Previously generated sections of this patent" does not contain a "Prior Art" section listing specific prior art references that were cited against this patent during prosecution or that are relevant for an obviousness determination. Without specific prior art documents, I am unable to identify combinations of references or explain motivations for combining them to render the claims obvious.

Generated 5/28/2026, 6:47:41 AM

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

Log in to generate
Not generated yet. Log in to request this analysis.

Derivative works

Defensive disclosure: derivative variations of each claim designed to render future incremental improvements obvious or non-novel.

Log in to generate
Not generated yet. Log in to request this analysis.

Keep exploring

More patents asserted by Unified Patents

Other patents in Software Technology & Computing Systems (T)

See all Software Technology & Computing Systems (T) patents →

This patent in court (2)

2 tracked lawsuits name US 9027032.